Current Management of Short Bowel Syndrome

Current Problems in Surgery

Volumn 49, Issue 2, 2012, Pages 52-115

  Thompson, Jon S ^a   Rochling, Fedja A ^b   Weseman, Rebecca A ^b   Mercer, David F ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ASCORBIC ACID; ATROPINE; CHOLECYSTOKININ; CITRATE CALCIUM; CLONIDINE; CODEINE; COLESTYRAMINE; CYCLOPHOSPHAMIDE; DIPHENOXYLATE; EPIDERMAL GROWTH FACTOR; EXENDIN 4; FOSCARNET; GANCICLOVIR; GLUCAGON LIKE PEPTIDE 2; GLUTAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HUMAN GROWTH HORMONE; KANAMYCIN A; LOPERAMIDE; OCTREOTIDE; OPIATE; PAREGORIC; PLACEBO; PROBIOTIC AGENT; PROKINETIC AGENT; PROTON PUMP INHIBITOR; TEDUGLUTIDE; UNINDEXED DRUG; VITAMIN D;

ABSENCE OF SIDE EFFECTS; ARTICLE; BIFIDOBACTERIUM BREVE; CATHETER INFECTION; CHOLELITHIASIS; COLON INTERPOSITION; CYTOMEGALOVIRUS INFECTION; D LACTIC ACIDODIS; D LACTIC ACIDOSIS; DIARRHEA; DIET THERAPY; DRUG DOSE COMPARISON; DRUG INTERMITTENT THERAPY; ENTERIC FEEDING; ESSENTIAL FATTY ACID DEFICIENCY; GASTROINTESTINAL DISEASE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTESTINAL FAILURE ASSOCIATED LIVER DISEASE; INTESTINE ABSORPTION; INTESTINE FLORA; INTESTINE ISCHEMIA; INTESTINE MOTILITY; INTESTINE TRANSIT TIME; INTESTINE TRANSPLANTATION; INTESTINE VILLUS; KIDNEY DYSFUNCTION; LACTOBACILLUS CASEI; LIVER DISEASE; LONG TERM CARE; LONG TERM SURVIVAL; LOW DRUG DOSE; LYMPHOPROLIFERATIVE DISEASE; MALABSORPTION; METABOLIC BONE DISEASE; NEPHROLITHIASIS; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL SUPPORT; OVERALL SURVIVAL; PARENTERAL NUTRITION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PROGNOSIS; QUALITY OF LIFE; SHORT BOWEL SYNDROME; SMALL BOWEL INTESTINAL BACTERIAL OVERGROWTH; SMALL INTESTINE RESECTION; STOMACH HYPERSECRETION; SURGICAL TECHNIQUE; TISSUE ENGINEERING; VASCULAR ACCESS; VEIN THROMBOSIS;

DISEASE MANAGEMENT; HUMANS; MORBIDITY; NUTRITION ASSESSMENT; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SHORT BOWEL SYNDROME; UNITED STATES;

EID: 84863413236     PISSN: 00113840     EISSN: 15356337     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2011.10.002     Document Type: Article

References (261)

1. O'Keefe S.J., Buchman A.L., Fishbein T.M., et al. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol 2006, 4:6-10.
2. Koeberle E. Resection de deux metres of intestine grele. Bull Acad Med 1881, 9:249-250.
3. Senn N. An experimental contribution to intestinal surgery with special reference to the treatment of intestinal obstruction. II Enterectomy. Ann Surg 1888, 7:92-115.
4. Mall F. Reversal of the intestine. Johns Hopkins Hosp Rep 1896, 1:93.
5. Flint J.M. The effect of extensive resections of the small intestine. Bull Johns Hopkins Hosp 1912, 23:127-144.
6. Haymond H.E. Massive resections of the small intestine. Surg Gynecol Obstet 1935, 61:693-705.
7. Simons B.E., Jordan G.L. Massive bowel resection. Am J Surg 1969, 118:953-959.
8. Wilmore D.W., Dudrick S.J. Growth and development of an infant receiving all nutrients exclusively by vein. JAMA 1968, 203:860-864.
9. Scribner B.H., Cole J.J., Christopher T.G., et al. Long-term total parenteral nutrition. The concept of an artificial gut. JAMA 1970, 212:457-463.
10. Dudrick S.J., O'Donnell J.J., Englert D.M., et al. 100 patient-years of ambulatory home total parenteral nutrition. Ann Surg 1984, 199:770-781.
11. Byrne T.A., Persinger R.L., Young L.S., et al. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg 1995, 222:243-254. [Discussion 254-5].
12. Grant D., Wall W., Mimeault R., et al. Successful small-bowel/liver transplantation. Lancet 1990, 335:181-184.
13. Bakker H., Bozzetti F., Staun M., et al. Home parenteral nutrition in adults: a European multicentre survey in 1997. ESPEN-Home Artificial Nutrition Working Group. Clin Nutr 1999, 18:135-140.
14. Howard L., Ament M., Fleming C.R., et al. Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology 1995, 109:355-365.
15. Thompson J.S. Comparison of massive vs. repeated resection leading to short bowel syndrome. J Gastrointest Surg 2000, 4:101-104.
16. Thompson J.S., Langnas A.N., Pinch L.W., et al. Surgical approach to short-bowel syndrome. Experience in a population of 160 patients. Ann Surg 1995, 222:600-605.
17. Messing B., Crenn P., Beau P., et al. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999, 117:1043-1050.
18. Wright H.K., Tilson M.D. The short gut syndrome: pathophysiology and treatment. Curr Probl Surg 1971, 3-51.
19. Wilmore D.W., Byrne T.A., Persinger R.L. Short bowel syndrome: new therapeutic approaches. Curr Probl Surg 1997, 34:389-444.
20. Quirós-Tejeira R.E., Ament M.E., Reyen L., et al. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience. J Pediatr 2004, 145:157-163.
21. Thompson J.S., DiBaise J.K., Iyer K.R., et al. Postoperative short bowel syndrome. J Am Coll Surg 2005, 201:85-89.
22. McBride C.L., Petersen A., Sudan D., et al. Short bowel syndrome following bariatric surgical procedures. Am J Surg 2006, 192:828-832.
23. Andrei V.E., Schein M., Wise L. Small bowel ischemia following laparoscopic cholecystectomy. Dig Surg 1999, 16:522-524.
24. Thompson J.S., Lynch T.S. Acute mesenteric arterial ischemia. Critical Controversies in Surgery 2001, 167-174. Springer, New York. M. Schein, L. Wise (Eds.).
25. Boland E., Thompson J., Rochling F., et al. A 25-year experience with postresection short-bowel syndrome secondary to radiation therapy. Am J Surg 2010, 200:690-693.
26. Thompson J.S., Iyer K.R., DiBaise J.K., et al. Short bowel syndrome and Crohn's disease. J Gastrointest Surg 2010, 7:1069-1072.
27. Thompson J.S., Gilroy R., Sudan D. Short bowel syndrome after continence-preserving procedures. J Gastrointest Surg 2008, 12:73-76.
28. Dabney A., Thompson J., DiBaise J., et al. Short bowel syndrome after trauma. Am J Surg 2004, 188:792-795.
29. Petty J.K., Ziegler M.M. Operative strategies for necrotizing enterocolitis: the prevention and treatment of short-bowel syndrome. Semin Pediatr Surg 2005, 14:191-198.
30. Thompson J.S. Strategies for preserving intestinal length in the short-bowel syndrome. Dis Colon Rectum 1987, 30:208-213.
31. Thompson J.S., Weseman R., Rochling F.A., et al. Preresection BMI influences post resection BMI in short bowel syndrome. Medimind Int Proc 2009, 103-109.
32. Underhill B.M. Intestinal length in man. Br Med J 1955, 2:1243-1246.
33. Fanucci A., Cerro P., Fraracci L., et al. Small bowel length measured by radiography. Gastrointest Radiol 1984, 9:349-351.
34. Nightingale J.M., Bartram C.I., Lennard-Jones J.E. Length of residual small bowel after partial resection: correlation between radiographic and surgical measurements. Gastrointest Radiol 1991, 16:305-306.
35. Carbonnel F., Cosnes J., Chevret S., et al. The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr 1996, 20:275-280.
36. Touloukian R.J., Smith G.J. Normal intestinal length in preterm infants. J Pediatr Surg 1983, 18:720-723.
37. Thompson J.S., Quigley E.M., Adrian T.E. Factors affecting outcome following proximal and distal intestinal resection in the dog: an examination of the relative roles of mucosal adaptation, motility, luminal factors, and enteric peptides. Dig Dis Sci 1999, 44:63-74.
38. Cosnes J., Gendre J.P., Le Quintrec Y. Role of the ileocecal valve and site of intestinal resection in malabsorption after extensive small bowel resection. Digestion 1978, 18:329-336.
39. Nordgaard I., Hansen B.S., Mortensen P.B. Colon as a digestive organ in patients with short bowel. Lancet 1994, 343:373-376.
40. Jeppesen P.B., Mortensen P.B. Significance of a preserved colon for parenteral energy requirements in patients receiving home parenteral nutrition. Scand J Gastroenterol 1998, 33:1175-1179.
41. Nightingale J.M., Lennard-Jones J.E., Gertner D.J., et al. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut 1992, 33:1493-1497.
42. Diamond I.R., Struijs M.C., de Silva N.T., et al. Does the colon play a role in intestinal adaptation in infants with short bowel syndrome?. A multiple variable analysis. J Pediatr Surg 2010, 45:975-979.
43. Thompson J.S., Weseman R., Rochling F.A., et al. Radiation therapy increases the risk of hepatobiliary complications in Short Bowel Syndrome. Nutr Clin Practice 2011, 26:474-478.
44. Jeppesen P.B. Clinical significance of GLP-2 in short-bowel syndrome. J Nutr 2003, 133:3721-3724.
45. Thompson J.S. Intestinal adaptation: nutritional and metabolic implications. Current Surgical Nutrition 1996, 147. Lanes, R.G., Austin, TX. R. Latifi, S.J. Dudrick (Eds.).
46. Helmrath M.A., Fong J.J., Dekaney C.M., et al. Rapid expansion of intestinal secretory lineages following a massive small bowel resection in mice. Am J Physiol Gastrointest Liver Physiol 2007, 292:G215-G222.
47. Garrison A.P., Dekaney C.M., von Allmen D.C., et al. Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion. Am J Physiol Gastrointest Liver Physiol 2009, 296:G643-G650.
48. Joly F., Mayeur C., Messing B., et al. Morphological adaptation with preserved proliferation/transporter content in the colon of patients with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2009, 297:G116-G123.
49. Tavakkolizadeh A., Whang E.E. Understanding and augmenting human intestinal adaptation: a call for more clinical research. JPEN J Parenter Enteral Nutr 2002, 26:251-255.
50. Quigley E.M., Thompson J.S. The motor response to intestinal resection: motor activity in the canine small intestine following distal resection. Gastroenterology 1993, 105:791-798.
51. Schmidt T., Pfeiffer A., Hackelsberger N., et al. Effect of intestinal resection on human small bowel motility. Gut 1996, 38:859-863.
52. Cosnes J., Carbonnel F., Beaugerie L., et al. Functional adaptation after extensive small bowel resection in humans. Eur J Gastroenterol Hepatol 1994, 6:197-202.
53. Buchman A.L., Scolapio J., Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003, 124:1111-1134.
54. Drozdowski L., Thomson A.B. Intestinal mucosal adaptation. World J Gastroenterol 2006, 12:4614-4627.
55. Madhavan S., Scow J.S., Chaudhry R.M., et al. Intestinal adaptation for oligopeptide absorption via PepT1 after massive (70%) mid-small bowel resection. J Gastrointest Surg 2011, 15:240-247.
56. Yang H., Fan Y., Finaly R., et al. Alteration of intestinal intraepithelial lymphocytes after massive small bowel resection. J Surg Res 2003, 110:276-286.
57. Mogilner J.G., Srugo I., Lurie M., et al. Effect of probiotics on intestinal regrowth and bacterial translocation after massive small bowel resection in a rat. J Pediatr Surg 2007, 42:1365-1371.
58. Ehrenfried J.A., Townsend C.M., Thompson J.C., et al. Increases in nup475 and c-jun are early molecular events that precede the adaptive hyperplastic response after small bowel resection. Ann Surg 1995, 222:51-56.
59. Rubin D.C., Swietlicki E.A., Wang J.L., et al. Enterocytic gene expression in intestinal adaptation: evidence for a specific cellular response. Am J Physiol 1996, 270:G143-G152.
60. Stephens A.N., Pereira-Fantini P.M., Wilson G., et al. Proteomic analysis of the intestinal adaptation response reveals altered expression of fatty acid binding proteins following massive small bowel resection. J Proteome Res 2010, 9:1437-1449.
61. Swietlicki E., Iordanov H., Fritsch C., et al. Growth factor regulation of PC4/TIS7, an immediate early gene expressed during gut adaptation after resection. JPEN J Parenter Enteral Nutr 2003, 27:123-131.
62. Rubin D.C., Levin M.S. Intestinal adaptation: molecular analyses of a complex process. Gastroenterology 1998, 115:1291-1294.
63. Erwin C.R., Falcone R.A., Stern L.E., et al. Analysis of intestinal adaptation gene expression by cDNA expression arrays. JPEN J Parenter Enteral Nutr 2000, 24:311-316.
64. Sudan D., DiBaise J., Torres C., et al. A multidisciplinary approach to the treatment of intestinal failure. J Gastrointest Surg 2010, 9:165-176.
65. Shatnawei A., Parekh N.R., Rhoda K.M., et al. Intestinal failure management at the Cleveland Clinic. Arch Surg 2010, 145:521-527.
66. DiBaise J.K., Young R.J., Vanderhoof J.A. Intestinal rehabilitation and the short bowel syndrome: part 1. Am J Gastroenterol 2004, 99:1386-1395.
67. DiBaise J.K., Young R.J., Vanderhoof J.A. Intestinal rehabilitation and the short bowel syndrome: Part 2. Am J Gastroenterol 2004, 99:1823-1832.
68. Rhoda K.M., Parekh N.R., Lennon E., et al. The multidisciplinary approach to the care of patients with intestinal failure at a tertiary care facility. Nutr Clin Pract 2010, 25:183-191.
69. Herman R., Btaiche I., Teitelbaum D.H. Nutrition support in the pediatric surgical patient. Surg Clin North Am 2011, 91:511-541.
70. Warren J., Bhalla V., Cresci G. Postoperative diet advancement: surgical dogma vs evidence-based medicine. Nutr Clin Pract 2011, 26:115-125.
71. Kudsk K.A., Croce M.A., Fabian T.C., et al. Enteral versus parenteral feeding. Effects on septic morbidity after blunt and penetrating abdominal trauma. Ann Surg 1992, 215:503-511.
72. Sigalet D.L., Mackenzie S.L., Hameed S.M. Enteral nutrition and mucosal immunity: implications for feeding strategies in surgery and trauma. Can J Surg 2004, 47:109-116.
73. Gramlich L., Kichian K., Pinilla J., et al. Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients?. A systematic review of the literature. Nutrition 2004, 20:843-848.
74. Shrikhande S.V., Shetty G.S., Singh K., et al. Is early feeding after major gastrointestinal surgery a fashion or an advance?. Evidence-based review of literature. J Cancer Res Ther 2009, 5:232-239.
75. Crenn P., Morin M.C., Joly F., et al. Net digestive absorption and adaptive hyperphagia in adult short bowel patients. Gut 2004, 53:1279-1286.
76. Cosnes J., Lamy P., Beaugerie L., et al. Adaptive hyperphagia in patients with postsurgical malabsorption. Gastroenterology 1990, 99:1814-1819.
77. Stout S.M., Cober M.P. Metabolic effects of cyclic parenteral nutrition infusion in adults and children. Nutr Clin Pract 2010, 25:277-281.
78. Richard D.M., Carlson G.L. Quality of life assessment and cost-effectiveness. Intestinal Failure 2001, 447-457. Greenwich Medical Media, Greenwich. J.M. Nightingale (Ed.).
79. Winkler M.F. Quality of life in adult home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 2005, 29:162-170.
80. Howard L. Home parenteral nutrition: survival, cost, and quality of life. Gastroenterology 2006, 130:S52-S59.
81. Huisman-de Waal G., Schoonhoven L., Jansen J., et al. The impact of home parenteral nutrition on daily life-a review. Clin Nutr 2007, 26:275-288.
82. Richards D.M., Hughes S.A., Irving M.H., et al. Patient quality of life after successful restorative proctocolectomy is normal. Colorectal Dis 2001, 3:223-226.
83. Jeppesen P.B., Langholz E., Mortensen P.B. Quality of life in patients receiving home parenteral nutrition. Gut 1999, 44:844-852.
84. Pironi L., Paganelli F., Mosconi P., et al. The SF-36 instrument for the follow-up of health-related quality-of-life assessment of patients undergoing home parenteral nutrition for benign disease. Transplant Proc 2004, 36:255-258.
85. Baxter J.P., Fayers P.M., McKinlay A.W. A review of the instruments used to assess the quality of life of adult patients with chronic intestinal failure receiving parenteral nutrition at home. Br J Nutr 2005, 94:633-638.
86. Baxter J.P., Fayers P.M., McKinlay A.W. A review of the quality of life of adult patients treated with long-term parenteral nutrition. Clin Nutr 2006, 25:543-553.
87. Baxter J.P., Fayers P.M., McKinlay A.W. The clinical and psychometric validation of a questionnaire to assess the quality of life of adult patients treated with long-term parenteral nutrition. JPEN J Parenter Enteral Nutr 2010, 34:131-142.
88. Gulledge A.D., Gipson W.T., Steiger E., et al. Home parenteral nutrition for the short bowel syndrome. Psychological issues. Gen Hosp Psychiatry 1980, 2:271-281.
89. Stern J.M., Jacyna N., Lloyd D.A. Review article: psychological aspects of home parenteral nutrition, abnormal illness behaviour and risk of self-harm in patients with central venous catheters. Aliment Pharmacol Ther 2008, 27:910-918.
90. Piamjariyakul U., Yadrich D.M., Ross V.M., et al. Complex home care: Part 2- family annual income, insurance premium, and out-of-pocket expenses. Nurs Econ 2010, 28:323-329.
91. Smith C.E., Piamjariyakul U., Yadrich D.M., et al. Complex home care: part III-economic impact on family caregiver quality of life and patients. Nurs Econ 2010, 28:393-399. 414.
92. Sudan D. Cost and quality of life after intestinal transplantation. Gastroenterology 2006, 130:S158-S162.
93. Vantini I., Benini L., Bonfante F., et al. Survival rate and prognostic factors in patients with intestinal failure. Dig Liver Dis 2004, 36:46-55.
94. Charney P. Computer technology and the nutrition support professional: make it work for you!. Nutr Clin Pract 2007, 22:421-427.
95. Systems HMI. HKS Medical Information Systems 2011, Omaha, Nebraska.
96. Marra A.R., Opilla M., Edmond M.B., et al. Epidemiology of bloodstream infections in patients receiving long-term total parenteral nutrition. J Clin Gastroenterol 2007, 41:19-28.
97. Srinivasan A., Wise M., Bell M., et al. Vital Signs: Central Line-Associated Bloodstream Infections-United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011, 60:243-248.
98. Timsit J.F., Dubois Y., Minet C., et al. New challenges in the diagnosis, management, and prevention of central venous catheter-related infections. Semin Respir Crit Care Med 2011, 32:139-150.
99. O'Grady N.P., Alexander M., Burns L.A., et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011, 52:e162-e193.
100. DeChicco R., Seidner D.L., Brun C., et al. Tip position of long-term central venous access devices used for parenteral nutrition. JPEN J Parenter Enteral Nutr 2007, 31:382-387.
101. DeLegge M.H., Borak G., Moore N. Central venous access in the home parenteral nutrition population-you PICC. JPEN J Parenter Enteral Nutr 2005, 29:425-428.
102. Crnich C.J., Halfmann J.A., Crone W.C., et al. The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access. Infect Contr Hosp Epidemiol 2005, 26:708-714.
103. Opilla M.T., Kirby D.F., Edmond M.B. Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 2007, 31:302-305.
104. Mouw E., Chessman K., Lesher A., et al. Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome. J Pediatr Surg 2008, 43:1025-1029.
105. Sanders J., Pithie A., Ganly P., et al. A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. J Antimicrob Chemother 2008, 62:809-815.
106. Cober M.P., Kovacevich D.S., Teitelbaum D.H. Ethanol-lock therapy for the prevention of central venous access device infections in pediatric patients with intestinal failure. JPEN J Parenter Enteral Nutr 2011, 35:67-73.
107. Onland W., Shin C.E., Fustar S., et al. Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. Arch Pediatr Adolesc Med 2006, 160:1049-1053.
108. Guerin K., Wagner J., Rains K., et al. Reduction in central line-associated bloodstream infections by implementation of a postinsertion care bundle. Am J Infect Contr 2010, 38:430-433.
109. de Csepel J., Stanley P., Padua E.M., et al. Maintaining long-term central venous access by repetitive hepatic vein cannulation. J Pediatr Surg 1994, 29:56-57.
110. Stavropoulos S.W., Pan J.J., Clark T.W., et al. Percutaneous transhepatic venous access for hemodialysis. J Vasc Interv Radiol 2003, 14:1187-1190.
111. Gupta A., Karak P.K., Saddekni S. Translumbar inferior vena cava catheter for long-term hemodialysis. J Am Soc Nephrol 1995, 5:2094-2097.
112. Versleijen M.W., Huisman-de Waal G.J., Kock M.C., et al. Arteriovenous fistulae as an alternative to central venous catheters for delivery of long-term home parenteral nutrition. Gastroenterology 2009, 136:1577-1584.
113. Recommended adult immunization schedule: United States 2011. Ann Intern Med 2011, 154:168-173. Advisory Committee on Immunization Practices.
114. Beath S., Pironi L., Gabe S., et al. Collaborative strategies to reduce mortality and morbidity in patients with chronic intestinal failure including those who are referred for small bowel transplantation. Transplantation 2008, 85:1378-1384.
115. Cavicchi M., Beau P., Crenn P., et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000, 132:525-532.
116. Chan S., McCowen K.C., Bistrian B.R., et al. Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition. Surgery 1999, 126:28-34.
117. Kelly D.A. Preventing parenteral nutrition liver disease. Early Hum Dev 2010, 86:683-687.
118. Mukherjee S., Sorrell M.F. Noninvasive tests for liver fibrosis. Semin Liver Dis 2006, 26:337-347.
119. Lassailly G., Caiazzo R., Hollebecque A., et al. Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity. Eur J Gastroenterol Hepatol 2011, 23:499-506.
120. Puder M., Valim C., Meisel J.A., et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009, 250:395-402.
121. Venick R.S., Calkins K. The impact of intravenous fish oil emulsions on pediatric intestinal failure-associated liver disease. Curr Opin Organ Transplant 2011, 16:306-311.
122. Jurewitsch B., Gardiner G., Naccarato M., et al. Omega-3-enriched lipid emulsion for liver salvage in parenteral nutrition-induced cholestasis in the adult patient. JPEN J Parenter Enteral Nutr 2011, 35:386-390.
123. Mertes N., Grimm H., Fürst P., et al. Safety and efficacy of a new parenteral lipid emulsion (SMOFlipid) in surgical patients: a randomized, double-blind, multicenter study. Ann Nutr Metab 2006, 50:253-259.
124. Piper S.N., Schade I., Beschmann R.B., et al. Hepatocellular integrity after parenteral nutrition: comparison of a fish-oil-containing lipid emulsion with an olive-soybean oil-based lipid emulsion. Eur J Anaesthesiol 2009, 26:1076-1082.
125. Thompson J.S. The role of prophylactic cholecystectomy in the short-bowel syndrome. Arch Surg 1996, 131:556-559. [Discussion 559-60].
126. Dray X., Joly F., Reijasse D., et al. Incidence, risk factors, and complications of cholelithiasis in patients with home parenteral nutrition. J Am Coll Surg 2007, 204:13-21.
127. Howard L., Ashley C. Management of complications in patients receiving home parenteral nutrition. Gastroenterology 2003, 124:1651-1661.
128. Fagan C., Phelan D. Severe convulsant hypomagnesaemia and short bowel syndrome. Anaesthesiol Intensive Care 2001, 29:281-283.
129. al-Ghamdi S.M., Cameron E.C., Sutton R.A. Magnesium deficiency: pathophysiologic and clinical overview. Am J Kidney Dis 1994, 24:737-752.
130. Petersen C. D-lactic acidosis. Nutr Clin Pract 2005, 20:634-645.
131. Halperin M.L., Kamel K.S. D-lactic acidosis: turning sugar into acids in the gastrointestinal tract. Kidney Int 1996, 49:1-8.
132. Hove H. Lactate and short chain fatty acid production in the human colon: implications for D-lactic acidosis, short-bowel syndrome, antibiotic-associated diarrhoea, colonic cancer, and inflammatory bowel disease. Dan Med Bull 1998, 45:15-33.
133. Uribarri J., Oh M.S., Carroll H.J. D-lactic acidosis. A review of clinical presentation, biochemical features, and pathophysiologic mechanisms. Medicine (Baltimore) 1998, 77:73-82.
134. Uchida H., Yamamoto H., Kisaki Y., et al. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg 2004, 39:634-636.
135. Modi B., Langer M., Duggan C., et al. Serial transverse enteroplasty for management of refractory D-lactic acidosis in short bowel syndrome. J Pediatr Gastroenterol Nutri 2006, 43:395-397.
136. Pironi L., Labate A.M., Pertkiewicz M., et al. Prevalence of bone disease in patients on home parenteral nutrition. Clin Nutr 2002, 21:289-296.
137. Haderslev K.V., Tjellesen L., Haderslev P.H., et al. Assessment of the longitudinal changes in bone mineral density in patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 2004, 28:289-294.
138. Cohen-Solal M., Baudoin C., Joly F., et al. Osteoporosis in patients on long-term home parenteral nutrition: a longitudinal study. J Bone Miner Res 2003, 18:1989-1994.
139. Ferrone M., Gevaci M. A review of the relationship between parenteral nutrition and metabolic bone disease. Nutr Clin Practice 2007, 22:329-339.
140. Resnick J., Gupta N., Wagner J., et al. Skeletal integrity and visceral transplantation. Am J Transplant 2010, 10:2331-2340.
141. Clinician's guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation 2008, Washigton, DC.
142. Kanis J.A. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002, 359:1929-1936.
143. Lewiecki E.M. Managing Osteoporosis: Challenges and Strategies. Cleveland Clinic Journal of Medicine 2009, 76:457-466.
144. Rachner T.D., Khosla S., Hofbauer L.C. Osteoporosis: now and the future. Lancet 2011, 377:1276-1287.
145. Tangpricha V., Luo M., Fernández-Estívariz C., et al. Growth hormone favorably affects bone turnover and bone mineral density in patients with short bowel syndrome undergoing intestinal rehabilitation. JPEN J Parenter Enteral Nutr 2006, 30:480-486.
146. Chadwick V.S., Modha K., Dowling R.H. Mechanism of hyperoxaliria in patients with ileal dysfunction. N Engl J Med 1973, 289:172-176.
147. Mole D.R., Tomson C.R., Mortensen N., et al. Renal complications of jejuno-ileal bypass for obesity. Q J Med 2001, 94:69-77.
148. Banerjee A., Warwickerk P. Acute renal failure and metabolic disturbance in the short bowel syndrome. Q J Med 2002, 95:37-40.
149. Akhavan A., Jackman S.V., Costa G., et al. Urogenital disorders associated with gut failure and intestinal transplantation. J Urol 2007, 178:2067-2072.
150. Kistler H., Peter J., Thiel G., et al. Seven-year survival of renal transplant for oxalate nephropathy due to short-bowel syndrome. Nephrol Dial Transplant 1995, 10:1466-1469.
151. Nunes P., Roseiro A., Mota A., et al. Renal transplantation in a short bowel syndrome patient. Transplant Proc 2003, 35:1067-1068.
152. Patel N., Smith S., Handa A., et al. The use of oral tacrolimus in a case of short bowel syndrome. Transpl Int 2004, 17:44-45.
153. Thompson J.S. Reoperation in patients with the short bowel syndrome. Am J Surg 1992, 164:453-456. [Discussion 456-7].
154. Hyman P.E., Everett S.L., Harada T. Gastric acid hypersecretion in short bowel syndrome in infants: association with extent of resection and enteral feeding. J Pediatr Gastroenterol Nutr 1986, 5:191-197.
155. Frederick P.L., Sizer J.S., Osborne M.P. Relation of massive bowel resection to gastric secretion. N Engl J Med 1965, 272:509-514.
156. Murphy J.P., King D.R., Dubois A. Treatment of gastric hypersecretion with cimetidine in the short-bowel syndrome. N Engl J Med 1979, 300:80-81.
157. Safioleas M., Stamatakos M., Safioleas P., et al. Short bowel syndrome: amelioration of diarrhea after vagotomy and pyloroplasty for peptic hemorrhage. Tohoku J Exp Med 2008, 214:7-10.
158. Quigley E.M., Abu-Shanab A. Small intestinal bacterial overgrowth. Infect Dis Clin North Am 2010, 24:943-959. viii-ix.
159. Stoidis C.N., Misiakos E.P., Patapis P., et al. Potential benefits of pro- and prebiotics on intestinal mucosal immunity and intestinal barrier in short bowel syndrome. Nutr Res Rev 2010, 1-9.
160. DiBaise J.K., Young R.J., Vanderhoof J.A. Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin Gastroenterol Hepatol 2006, 4:11-20.
161. Vanderhoof J.A., Young R.J., Murray N., et al. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr 1998, 27:155-160.
162. Joly F., Mayeur C., Bruneau A., et al. Drastic changes in fecal and mucosa-associated microbiota in adult patients with short bowel syndrome. Biochimie 2010, 92:753-761.
163. Singh V.V., Toskes P.P. Small Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment. Curr Treat Options Gastroenterol 2004, 7:19-28.
164. Corazza G.R., Menozzi M.G., Strocchi A., et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 1990, 98:302-309.
165. Quigley E.M., Quera R., Abu-Shanab A. The enteric flora in intestinal failure. Intestinal Failure 2008, vol 1:167-184. Blackwell Publishing, Malden, MA.
166. Compare D., Pica L., De Giorgi F., et al. Effects of long term PPI treatment in producing bowel symptoms and SIBO. Eur J Clin Invest 2010, 10:1365-2362.
167. Zhang H., DiBaise J.K., Zuccolo A., et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009, 106:2365-2370.
168. Turnbaugh P.J., Ley R.E., Mahowald M.A., et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
169. Cani P.D., Delzenne N.M. The gut microbiome as therapeutic target. Pharmacol Ther 2011, 130:202-212.
170. DiBaise J.K., Zhang H., Crowell M.D., et al. Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 2008, 83:460-469.
171. Savage D.C. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977, 31:107-133.
172. Goulet O., Joly F. [Intestinal microbiota in short bowel syndrome]. Gastroenterol Clin Biol 2010, 34(Suppl 1):S37-S43.
173. Joly F., Mayeur C., Bruneau A., et al. Drastic changes in fecal and mucosa-associated microbiota in adult patients with short bowel syndrome. Biochimie 2010, 92:753-761.
174. Hartman A.L., Lough D.M., Barupal D.K., et al. Human gut microbiome adopts an alternative state following small bowel transplantation. Proc Natl Acad Sci USA 2009, 106:17187-17192.
175. Crenn P., Coudray-Lucas C., Thuillier F., et al. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000, 119:1496-1505.
176. Lou M., Fernandez C., Manatunga A., et al. Are plasma citrulline and glutamine biomarkers of intestinal absorptive function in patients with short bowel syndrome?. J Parenter Enteral Nutr 2007, 31:1-7.
177. MacMahon R.A. The use of the World Health Organization's oral rehydration solution in patients on home parenteral nutrition. JPEN J Parenter Enteral Nutr 1984, 8:720-721.
178. Atia A.N., Buchman A.L. Oral rehydration solutions in non-cholera diarrhea: a review. Am J Gastroenterol 2009, 104:2596-2604. [Quiz 2605].
179. Thompson J.S., Weseman R., Rochling F.A., et al. Current management of the short bowel syndrome. Surg Clin North Am 2011, 91:493-510.
180. Westergaard H. Bile acid malabsorption. Curr Treat Options Gastroenterol 2007, 10:28-33.
181. Jeppesen P.B., Staun M., Tjellesen L., et al. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection. Gut 1998, 43:763-769.
182. O'Keefe S.J., Haymond M.W., Bennet W.M., et al. Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology 1994, 107:379-388.
183. Catnach S.M., Anderson J.V., Fairclough P.D., et al. Effect of octreotide on gall stone prevalence and gall bladder motility in acromegaly. Gut 1993, 34:270-273.
184. McDoniel K., Taylor B., Huey W., et al. Use of clonidine to decrease intestinal fluid losses in patients with high-output short-bowel syndrome. JPEN J Parenter Enteral Nutr 2004, 28:265-268.
185. Buchman A.L., Fryer J., Wallin A., et al. Clonidine reduces diarrhea and sodium loss in patients with proximal jejunostomy: a controlled study. JPEN J Parenter Enteral Nutr 2006, 30:487-491.
186. Ward N. The impact of intestinal failure on oral drug absorption: a review. J Gastrointest Surg 2010, 14:1045-1051.
187. Chandra P., Wolfenden L.L., Ziegler T.R., et al. Treatment of vitamin D deficiency with UV light in patients with malabsorption syndromes: a case series. Photodermatol Photoimmunol Photomed 2007, 23:179-185.
188. Wilmore D.W., Lacey J.M., Soultanakis R.P., et al. Factors predicting a successful outcome after pharmacologic bowel compensation. Ann Surg 1997, 226:288-292. [Discussion 292-3].
189. Jeppesen P.B. The use of hormonal growth factors in the treatment of patients with short-bowel syndrome. Drugs 2006, 66:581-589.
190. Szkudlarek J., Jeppesen P.B., Mortensen P.B. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study. Gut 2000, 47:199-205.
191. Scolapio J.S., Camilleri M., Fleming C.R., et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997, 113:1074-1081.
192. Byrne T.A., Morrissey T.B., Nattakom T.V., et al. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN J Parenter Enteral Nutr 1995, 19:296-302.
193. Seguy D., Vahedi K., Kapel N., et al. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology 2003, 124:293-302.
194. Jeppesen P.B., Sanguinetti E.L., Buchman A., et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 2005, 54:1224-1231.
195. Jeppesen P.B., Hartmann B., Thulesen J., et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 2001, 120:806-815.
196. Jeppesen P.B., Lund P., Gottschalck I.B., et al. Short bowel patients treated for two years with glucagon-like Peptide 2: effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle function. Gastroenterol Res Pract 2009, 2009. 616054.
197. Jeppesen P.B., Gilroy R., Pertkiewicz M., et al. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut 2011, 60:902-914.
198. Koopmann M.C., Chen X., Holst J.J., et al. Sustained glucagon-like peptide-2 infusion is required for intestinal adaptation, and cessation reverses increased cellularity in rats with intestinal failure. Am J Physiol Gastrointest Liver Physiol 2010, 299:G1222-G1230.
199. Sham J., Martin G., Meddings J.B., et al. Epidermal growth factor improves nutritional outcome in a rat model of short bowel syndrome. J Pediatr Surg 2002, 37:765-769.
200. Thompson J.S. Epidermal growth factor and the short bowel syndrome. JPEN J Parenter Enteral Nutr 1999, 23:S113-S116.
201. Sigalet D.L., Martin G.R., Butzner J.D., et al. A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome. J Pediatr Surg 2005, 40:763-768.
202. Kunkel D., Basseri B., Low K., et al. Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome. Neurogastroenterol Motil 2011, 23:739-745.
203. Wales P.W., Nasr A., de Silva N., et al. Human growth hormone and glutamine for patients with short bowel syndrome. Cochrane Database Syst Rev 2010, CD006321.
204. Yazbeck R., Abbott C.A., Howarth G.S. The use of GLP-2 and related growth factors in intestinal diseases. Curr Opin Investig Drugs 2010, 11:440-446.
205. Dubé P.E., Brubaker P.L. Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators. Am J Physiol Endocrinol Metab 2007, 293:E460-E465.
206. Rowland K.J., Brubaker P.L. Life in the crypt: a role for glucagon-like peptide-2?. Mol Cell Endocrinol 2008, 288:63-70.
207. Rowland K.J., Brubaker P.L. The "cryptic" mechanism of action of glucagon-like peptide-2. Am J Physiol Gastrointest Liver Physiol 2011, 301:G1-G8.
208. Drucker D.J., Erlich P., Asa S.L., et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 1996, 93:7911-7916.
209. Hornby P.J., Moore B.A. The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease. Exp Opin Ther Targets 2011, 15:637-646.
210. Iltz J.L., Baker D.E., Setter S.M., et al. Exenatide: an incretin mimetic for the treatment of type 2 diabetes mellitus. Clin Ther 2006, 28:652-665.
211. Thompson J.S., Langnas A.N. Surgical approaches to improving intestinal function in the short-bowel syndrome. Arch Surg 1999, 134:706-709. [Discussion 709-11].
212. Nguyen B.T., Blatchford G.J., Thompson J.S., et al. Should intestinal continuity be restored after massive intestinal resection?. Am J Surg 1989, 158:577-579. [Discussion 579-80].
213. Jeppesen P.B., Mortensen P.B. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut 1998, 43:478-483.
214. Diamond I.R., Wales P.W. Advantages of the distal sigmoid colostomy in the management of infants with short bowel syndrome. J Pediatr Surg 2008, 43:1464-1467.
215. Thompson J.S. Surgical approach to the short-bowel syndrome: procedures to slow intestinal transit. Eur J Pediatr Surg 1999, 9:263-266.
216. Panis Y., Messing B., Rivet P., et al. Segmental reversal of the small bowel as an alternative to intestinal transplantation in patients with short bowel syndrome. Ann Surg 1997, 225:401-407.
217. Thompson J.S., Quigley E.M., Adrian T.E. Effect of reversed intestinal segments on intestinal structure and function. J Surg Res 1995, 58:19-27.
218. Digalakis M., Papamichail M., Glava C., et al. Interposition of a reversed jejunal segment enhances intestinal adaptation in short bowel syndrome: an experimental study on pigs. J Surg Res 2011, 171:551-557.
219. Kozlowski D., Lescut D., Gambiez L. Surgically reversed segment of small bowel segment in Crohn's disease. Gastroenterology 1999, 116:A688.
220. Thompson J.S., Sudan D.A., Gilroy R. Predicting outcome of procedures to slow intestinal transit. Transplant Proc 2006, 38:1838-1839.
221. Quigley E.M., Thompson J.S., Lof J. Disruption of canine jejunal interdigestive myoelectrical activity by artificial ileocolonic sphincter. Studies of intestinal motor response to surgically fashioned sphincter substitute. Dig Dis Sci 1989, 34:1434-1442.
222. Zurita M., Raurich J.M., Ramírez A., et al. A new neovalve type in short bowel syndrome surgery. Rev Esp Enferm Dig 2004, 96:110-118.
223. Georgeson K., Halpin D., Figueroa R., et al. Sequential intestinal lengthening procedures for refractory short bowel syndrome. J Pediatr Surg 1994, 29:316-320. [Discussion 320-1].
224. Kono K., Sekikawa T., Iizuka H., et al. Interposed colon between remnants of the small intestine exhibits small bowel features in a patient with short bowel syndrome. Dig Surg 2001, 18:237-241.
225. Yagi T., Nakagawa K., Sadamori H., et al. Antiperistaltic transverse colostomy for massive bowel necrosis following surgery for an abdominal aortic aneurysm: report of a case. Surg Today 1997, 27:554-558.
226. Bianchi A. Longitudinal intestinal lengthening and tailoring: results in 20 children. J R Soc Med 1997, 90:429-432.
227. Kim H.B., Fauza D., Garza J., et al. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg 2003, 38:425-429.
228. Javid P.J., Kim H.B., Duggan C.P., et al. Serial transverse enteroplasty is associated with successful short-term outcomes in infants with short bowel syndrome. J Pediatr Surg 2005, 40:1019-1023. [Discussion 1023-4].
229. Thompson J.S., Quigley E.M., Adrian T.E. Effect of intestinal tapering and lengthening on intestinal structure and function. Am J Surg 1995, 169:111-119.
230. Bonnard A., Staub G., Segura J.F., et al. Evaluation of intestinal absorption after longitudinal intestinal lengthening for short bowel syndrome. J Pediatr Surg 2005, 40:1587-1591.
231. Thompson J.S., Pinch L.W., Young R., et al. Long-term outcome of intestinal lengthening. Transplant Proc 2000, 32:1242-1243.
232. Sudan D., Thompson J., Botha J., et al. Comparison of intestinal lengthening procedures for patients with short bowel syndrome. Ann Surg 2007, 246:593-601. [Discussion 601-4].
233. Thompson J., Sudan D. Intestinal lengthening for short bowel syndrome. Adv Surg 2008, 42:49-61.
234. Walker S.R., Nucci A., Yaworski J.A., et al. The Bianchi procedure: a 20-year single institution experience. J Pediatr Surg 2006, 41:113-119.
235. Modi B.P., Javid P.J., Jaksic T., et al. First report of the international serial transverse enteroplasty data registry: indications, efficacy, and complications. J Am Coll Surg 2007, 204:365-371.
236. Reinshagen K., Kabs C., Wirth H., et al. Long-term outcome in patients with short bowel syndrome after longitudinal intestinal lengthening and tailoring. J Pediatr Gastroenterol Nutr 2008, 47:573-578.
237. Modi B.P., Ching Y.A., Langer M., et al. Preservation of intestinal motility after the serial transverse enteroplasty procedure in a large animal model of short bowel syndrome. J Pediatr Surg 2009, 44:229-235.
238. Andres A.M., Thompson J., Grant W., et al. Repeat Surgical bowel lengthening with the STEP procedure. Transplantation 2008, 85:1294-1299.
239. Miyasaka E.A., Brown P.I., Teitelbaum D.H. Redilation of bowel after intestinal lengthening procedures-an indicator for poor outcome. J Pediatr Surg 2011, 46:145-149.
240. Yannam G.R., Sudan D.L., Grant W., et al. Intestinal lengthening in adult patients with short bowel syndrome. J Gastrointest Surg 2010, 14:1931-1936.
241. Thompson J.S., Harty R.J., Saigh J.A., et al. Morphologic and nutritional responses to intestinal patching following intestinal resection. Surgery 1988, 103:79-86.
242. Nguyen B.L., Thompson J.S. Growing small-intestinal neomucosa in serosa-lined pouches. Curr Surg 1990, 47:269-271.
243. Stelzner M., Chen D.C. To make a new intestinal mucosa. Rejuvenation Res 2006, 9:20-25.
244. Vacanti J.P. Tissue and organ engineering: can we build intestine and vital organs?. J Gastrointest Surg 2003, 7:831-835.
245. Dekaney C.M., Rodriguez J.M., Graul M.C., et al. Isolation and characterization of a putative intestinal stem cell fraction from mouse jejunum. Gastroenterology 2005, 129:1567-1580.
246. Sala F.G., Kunisaki S.M., Ochoa E.R., et al. Tissue-engineered small intestine and stomach form from autologous tissue in a preclinical large animal model. J Surg Res 2009, 156:205-212.
247. Grikscheit T.C., Siddique A., Ochoa E.R., et al. Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg 2004, 240:748-754.
248. Rocha F.G., Sundback C.A., Krebs N.J., et al. The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. Biomaterials 2008, 29:2884-2890.
249. Kelly D.A. Liver complications of pediatric parenteral nutrition-epidemiology. Nutrition 1998, 14:153-157.
250. Abu-Elmagd K.M., Costa G., Bond G.J., et al. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg 2009, 250:567-581.
251. Mazariegos G.V., Steffick D.E., Horslen S., et al. Intestine transplantation in the United States, 1999-2008. Am J Transplant 2010, 10:1020-1034.
252. Sindhi R., Landmark J., Shaw B.W., et al. Combined liver/small bowel transplantation using a blood group compatible but nonidentical donor. Transplantation 1996, 61:1782-1783.
253. Grant W., Langnas A.N. Pediatric small bowel transplantation: techniques and outcomes. Curr Opin Organ Transplant 2002, 7:202-2007.
254. Reyes J., Mazariegos G.V., Abu-Elmagd K., et al. Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). Am J Transplant 2005, 5:1430-1436.
255. Kato T., Gaynor J.J., Selvaggi G., et al. Intestinal transplantation in children: a summary of clinical outcomes and prognostic factors in 108 patients from a single center. J Gastrointest Surg 2005, 9:75-89. [Discussion 89].
256. Grant W., Botha J.F., Sudan D.L., et al. Improved survival after intestinal transplantation with lower immunosuppression, IX International Small Bowel Transplantation Symposium June 30, 2005, 2005.
257. Grant D., Abu-Elmagd K., Reyes J., et al. Report of the intestine transplant registry: a new era has dawned. Ann Surg 2003, 2005(241):607-613.
258. Gross T.G., Hinrichs S.H., Winner J., et al. Treatment of post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation with low-dose chemotherapy. Ann Oncol 1998, 9:339-340.
259. O'Keefe S.I.D., Emerling M., Kovitsky D., et al. Nutrition and quality of life following small intestinal transplantation. Am J Gastroenterol 2007, 102:1093-1100.
260. Sudan D. Long-term outcomes and quality of life after intestine transplantation. Curr Opin Organ Transplant 2010, 15:357-360.
261. Gupte G.L., Beath S.V. Update on intestinal rehabilitation after intestinal transplantation. Curr Opin Organ Transplant 2009, 14:267-273.